Quarterly Updates21 May 2026, 01:28 pm
Krebs Biochemicals FY26: Revenue ₹2,373.16 Lacs
AI Summary
Krebs Biochemicals & Industries Ltd reported audited financial results for the year ended March 31, 2026. The Board of Directors approved the results at a meeting held on May 21, 2026. Revenue from Operations stood at ₹2,373.16 lacs, while the company reported a loss before tax of ₹1,693.31 lacs. The Statutory Auditors issued an unmodified report on the financial statements. The Vizag manufacturing unit remains closed following an order from the Andhra Pradesh Pollution Control Board.
Key Highlights
- Revenue from Operations for FY26 is ₹2,373.16 lacs.
- Loss before tax for FY26 is ₹1,693.31 lacs.
- The Statutory Auditors issued an unmodified audit report.
- Vizag manufacturing unit remains closed due to pollution control order.
- Board meeting approved results on May 21, 2026.
Price Impact
More from KREBSBIO